GL1X · GenesisL1 explorer

Research workbench

Structure of human SARS-cov-2 neutralizing antibody C1C-A3 Fab

Analyse Structure of human SARS-cov-2 neutralizing antibody C1C-A3 Fab in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7SN1
Type
protein
Length
430 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neutralizing antibody C1C-A3 Fab heavy chain; Neutralizing antibody C1C-A3 Fab light chain
Pockets
4 · best druggability 0.63

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HNeutralizing antibody C1C-A3 Fab heavy chainprotein2169% helix, 54% strand—
LNeutralizing antibody C1C-A3 Fab light chainprotein2145% helix, 52% strand—

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16200.630.7463empty
2580.450.8425empty
31330.450.7725empty
4690.290.7316empty

Interfaces

1 interface between chains.

  • H–L · 1784 Ų buried · 19 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 7SN1 · Structure of human SARS-CoV-2 neutralizing antibody C1C-A3 Fab · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.